Navarro-Zaragoza J, Núñez C, Laorden ML, Milanés MV. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Mol Pharmacol. 2010 May;77(5):864-73. doi: 10.1124/mol.109.062463. Epub 2010 Feb 16. PubMed PMID: 20159948.
AÑO: 2010; IF: 4.436
|
Núñez C, Martín F, Földes A, Luisa Laorden M, Kovács KJ, Victoria Milanés M. Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal. J Neurochem. 2010 Jul;114(2):475-87. doi: 10.1111/j.1471-4159.2010.06765.x. Epub 2010 Apr 23. PubMed PMID: 20438612.
AÑO: 2010; IF: 4.337
|
Ferenczi S, Núñez C, Pintér-Kübler B, Földes A, Martín F, Márkus VL, Milanés MV, Kovács KJ. Changes in metabolic-related variables during chronic morphine treatment. Neurochem Int. 2010 Oct;57(3):323-30. doi: 10.1016/j.neuint.2010.06.011. Epub 2010 Jun 26. PubMed PMID: 20600437.
AÑO: 2010; IF: 3.601
|
Navarro-Zaragoza J, Núñez C, Ruiz-Medina J, Laorden ML, Valverde O, Milanés MV. CRF? mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats. Br J Pharmacol. 2011 Feb;162(4):851-62. doi: 10.1111/j.1476-5381.2010.01090.x. PubMed PMID: 20973778; PubMed Central PMCID: PMC3042196.
AÑO: 2011; IF: 8.739
|
García-Pérez D, Laorden ML, Milanés MV, Núñez C. Glucocorticoids regulation of FosB/?FosB expression induced by chronic opiate exposure in the brain stress system. PLoS One. 2012;7(11):e50264. doi: 10.1371/journal.pone.0050264. Epub 2012 Nov 21. PubMed PMID: 23185589; PubMed Central PMCID: PMC3503985.
AÑO: 2012; IF: 3.73
|
Pabellón Docente del Hospital
Clínico Universitario Virgen de la Arrixaca - 3ª Planta
C/ Campo 12, 30120 - El Palmar - Murcia, España
+34 968359767
+34 968381298